These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 2160518

  • 1. Excitatory amino acid binding sites in the hippocampal region of Alzheimer's disease and other dementias.
    Penney JB, Maragos WF, Greenamyre JT, Debowey DL, Hollingsworth Z, Young AB.
    J Neurol Neurosurg Psychiatry; 1990 Apr; 53(4):314-20. PubMed ID: 2160518
    [Abstract] [Full Text] [Related]

  • 2. Alzheimer's disease: changes in hippocampal N-methyl-D-aspartate, quisqualate, neurotensin, adenosine, benzodiazepine, serotonin and opioid receptors--an autoradiographic study.
    Jansen KL, Faull RL, Dragunow M, Synek BL.
    Neuroscience; 1990 Apr; 39(3):613-27. PubMed ID: 1965859
    [Abstract] [Full Text] [Related]

  • 3. Dementia of the Alzheimer's type: changes in hippocampal L-[3H]glutamate binding.
    Greenamyre JT, Penney JB, D'Amato CJ, Young AB.
    J Neurochem; 1987 Feb; 48(2):543-51. PubMed ID: 2878980
    [Abstract] [Full Text] [Related]

  • 4. Hippocampal excitatory amino acid receptors in elderly, normal individuals and those with Alzheimer's disease: non-N-methyl-D-aspartate receptors.
    Geddes JW, Ułas J, Brunner LC, Choe W, Cotman CW.
    Neuroscience; 1992 Sep; 50(1):23-34. PubMed ID: 1328933
    [Abstract] [Full Text] [Related]

  • 5. A study of cortical and hippocampal NMDA and PCP receptors following selective cortical and subcortical lesions.
    Maragos WF, Greenamyre JT, Chu DC, Penney JB, Young AB.
    Brain Res; 1991 Jan 04; 538(1):36-45. PubMed ID: 1850317
    [Abstract] [Full Text] [Related]

  • 6. N-methyl-D-aspartate receptor complex in the hippocampus of elderly, normal individuals and those with Alzheimer's disease.
    Ułas J, Brunner LC, Geddes JW, Choe W, Cotman CW.
    Neuroscience; 1992 Jul 04; 49(1):45-61. PubMed ID: 1407551
    [Abstract] [Full Text] [Related]

  • 7. NMDA receptor losses in putamen from patients with Huntington's disease.
    Young AB, Greenamyre JT, Hollingsworth Z, Albin R, D'Amato C, Shoulson I, Penney JB.
    Science; 1988 Aug 19; 241(4868):981-3. PubMed ID: 2841762
    [Abstract] [Full Text] [Related]

  • 8. Glutamate metabotropic and AMPA binding sites are reduced in Alzheimer's disease: an autoradiographic study of the hippocampus.
    Dewar D, Chalmers DT, Graham DI, McCulloch J.
    Brain Res; 1991 Jul 05; 553(1):58-64. PubMed ID: 1933277
    [Abstract] [Full Text] [Related]

  • 9. Autoradiographic characterization of N-methyl-D-aspartate-, quisqualate- and kainate-sensitive glutamate binding sites.
    Greenamyre JT, Olson JM, Penney JB, Young AB.
    J Pharmacol Exp Ther; 1985 Apr 05; 233(1):254-63. PubMed ID: 2984415
    [Abstract] [Full Text] [Related]

  • 10. NMDA, AMPA, and benzodiazepine binding site changes in Alzheimer's disease visual cortex.
    Carlson MD, Penney JB, Young AB.
    Neurobiol Aging; 1993 Apr 05; 14(4):343-52. PubMed ID: 7690114
    [Abstract] [Full Text] [Related]

  • 11. Characterization of the inhibition of excitatory amino acid-induced neurotransmitter release in the rat striatum by phencyclidine-like drugs.
    Snell LD, Johnson KM.
    J Pharmacol Exp Ther; 1986 Sep 05; 238(3):938-46. PubMed ID: 2875174
    [Abstract] [Full Text] [Related]

  • 12. Excitatory amino acid binding sites in the caudate nucleus and frontal cortex of Huntington's disease.
    Dure LS, Young AB, Penney JB.
    Ann Neurol; 1991 Dec 05; 30(6):785-93. PubMed ID: 1665055
    [Abstract] [Full Text] [Related]

  • 13. Altered excitatory and inhibitory amino acid receptor binding in hippocampus of patients with temporal lobe epilepsy.
    McDonald JW, Garofalo EA, Hood T, Sackellares JC, Gilman S, McKeever PE, Troncoso JC, Johnston MV.
    Ann Neurol; 1991 May 05; 29(5):529-41. PubMed ID: 1650160
    [Abstract] [Full Text] [Related]

  • 14. Density and distribution of NMDA receptors in the human hippocampus in Alzheimer's disease.
    Geddes JW, Chang-Chui H, Cooper SM, Lott IT, Cotman CW.
    Brain Res; 1986 Dec 03; 399(1):156-61. PubMed ID: 2879613
    [Abstract] [Full Text] [Related]

  • 15. Differential alterations of cortical glutamatergic binding sites in senile dementia of the Alzheimer type.
    Chalmers DT, Dewar D, Graham DI, Brooks DN, McCulloch J.
    Proc Natl Acad Sci U S A; 1990 Feb 03; 87(4):1352-6. PubMed ID: 2154742
    [Abstract] [Full Text] [Related]

  • 16. Loss of hippocampal [3H]TCP binding in Alzheimer's disease.
    Maragos WF, Chu DC, Young AB, D'Amato CJ, Penney JB.
    Neurosci Lett; 1987 Mar 09; 74(3):371-6. PubMed ID: 3031556
    [Abstract] [Full Text] [Related]

  • 17. [3H]TCP binding sites in Alzheimer's disease.
    Monaghan DT, Geddes JW, Yao D, Chung C, Cotman CW.
    Neurosci Lett; 1987 Jan 14; 73(2):197-200. PubMed ID: 3029638
    [Abstract] [Full Text] [Related]

  • 18. Inhibitory and excitatory amino acid neurotransmitter binding sites in cynomolgus monkey (Macaca fascicularis) cervical spinal cord.
    Albin RL, Hollingsworth Z, Sakurai SY, Gilman S.
    Brain Res; 1993 Feb 26; 604(1-2):354-7. PubMed ID: 8096159
    [Abstract] [Full Text] [Related]

  • 19. Phencyclidine produces changes in NMDA and kainate receptor binding in rat hippocampus over a 48-hour time course.
    Gao XM, Tamminga CA.
    Synapse; 1996 Aug 26; 23(4):274-9. PubMed ID: 8855512
    [Abstract] [Full Text] [Related]

  • 20. Autoradiographic localisation of NMDA, quisqualate and kainic acid receptors in human spinal cord.
    Jansen KL, Faull RL, Dragunow M, Waldvogel H.
    Neurosci Lett; 1990 Jan 01; 108(1-2):53-7. PubMed ID: 1689476
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.